Skip to main content

Clinical trial AMG420 -20160370

A Phase 1b/2 Multicenter, Open-label, Expansion Study to Assess the Safety and Efficacy of AMG 420 as Monotherapy in Subjects With Relapsed and/or Refractory Multiple Myeloma

Trial status Trial closed for recruitment
Investigator
Trial type
Interventional with experimental drug
Phase Trial phase 1/2
Academic trial Non
Sponsor Amgen
EudraCT Identifier 2018-002879-17
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03836053
Last update